SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) January 16, 2004 Millennium Cell Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-31083 22-3726792 (State or Other Jurisdiction (Commission File (IRS Employer of Incorporation) Number) Identification No.) 1 Industrial Way West, Eatontown, New Jersey 07724 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (732) 542-4000 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Item 5. Other Events On February 18, 2004, Millennium Cell Inc. issued a press release announcing the completion of a $6 million private placement financing, part of a $10 million financing announced by the company on January 20, 2004. On February 17, 2004, the company issued a $6 million convertible debenture to an accredited investor having an initial conversion price of $3.30 per share. A copy of the press release is filed as Exhibit 99.1 to this report. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MILLENNIUM CELL INC. (Registrant) By: /s/ Stephen S. Tang ------------------- Stephen S. Tang, Ph.D. President, CEO & Acting CFO Dated: February 18, 2004